BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
KLK3
,
glucose metabolic process
,
HIV infection
,
Kidney
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LILRB2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Macrophage of peripheral blood
Myeloid cells of peripheral blood
Neutrophil of bone marrow
Monocyte of peripheral blood
Leukocyte (polymorphonuclear) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Contact dermatitis
Acne
Disease due to Orthopoxvirus
Spotted fevers
Anthrax
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Pivampicillin
epitiostanol
Hesperidin
Demeclocycline
Yohimbine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR124-1
NEUROG1
IL10RB
DNAJB2
CLK3
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
ILT4 facilitates angiogenesis in non-small cell lung cancer.
Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer.
ILT4 reprograms glucose metabolism to promote tumor progression in triple-negative breast cancer.
Dexamethasone promotes renal fibrosis by upregulating ILT4 expression in myeloid-derived suppressor …
Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of JTX 8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With A…
Dose Confirmation and Dose Expansion Study of IO-108 and IO-108 + Pembrolizumab in Solid Tumors
Phase 1b Study of IO-108 as Monotherapy and in Combination With a PD-1 Inhibitor in Solid Tumors
Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors
Infections and Unexplained Infertility
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ